Smoking is the leading cause of preventable death and disease in England. Rates of smoking increased by 25% among people aged 18–34 years in England during the first COVID-19 lockdown. This resource outlines how pharmacists and pharmacy teams can support patients with smoking cessation through effective consultations and advice on nicotine replacement therapy (NRT).
Click here for the full PDF of this resource
- 1Smoking statistics. Action on Smoking and Health (ASH). 2021.https://ash.org.uk/wp-content/uploads/2019/10/SmokingStatistics.pdf (accessed Oct 2021).
- 2Jackson SE, Beard E, Angus C, et al. Moderators of changes in smoking, drinking and quitting behaviour associated with the first COVID‐19 lockdown in England. Addiction. 2021. doi:10.1111/add.15656
- 3Stop smoking interventions and services. NICE guideline [NG92]. National Institute for Health and Care Excellence. 2018.https://www.nice.org.uk/guidance/ng92/chapter/recommendations (accessed Oct 2021).
- 4Hartmann-Boyce J, Chepkin SC, Ye W, et al. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews. 2018;2019. doi:10.1002/14651858.cd000146.pub5
- 5Stop smoking services: increased chances of quitting. National Centre for Smoking Cessation and Training (NCSCT). 2019.https://www.ncsct.co.uk/usr/pub/Stop%20smoking%20services%20effectiveness.pdf (accessed Oct 2021).
- 6Stepping up: The response of stop smoking services in England to the COVID-19 pandemic. Action on Smoking and Health (ASH). 2021.https://ash.org.uk/information-and-resources/reports-submissions/reports/steppingup/ (accessed Oct 2021).